Taysha Gene Therapies (Nasdaq: TSHA) announced the completion of dosing in its REVEAL pivotal trial and released longer-term clinical data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE